Rebalix
Logo VanguardVanguard · sheet of 5 September 2026
ETF sheet · official issuer and register data

Vanguard FTSE 100 UCITS ETF (GBP) Distributing

VUKE · IE00B810Q511 · GBP · domicile Ireland
Equity · United Kingdom · Large capSFDR art. 6 (inferred)
Index tracked: FTSE 100 Index
TER
0.09%+ trans. 0.02%
Fund size
7.8 bn EUR
Tracking difference
−0.13%3-year avg
🇮🇹 tax rate
26.00%equity
Replication
Physical (sampled)
Income
Distributingquarterly
Launch 22 May 2012 · costs from the KID as of 2 Sept 2026 · 108 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE 100 Index (the “Index”). The Index is comprised of large-sized company stocks in the UK. The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in…

Performance since series start (in euro) — base 100

30 Jun 201231 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2013201520172019202120232025306100306
High 306 (31 Jul 2026) · low 100 (30 Jun 2012) · last 306. Past performance is not indicative of future results.

Returns in euro

1 year+27.9%
3 years+56.8%
5 years+85.0%
10 years+132.7%
Since series start+206.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.43%11.28%12.71%
Max drawdown−9.66%−13.74%−13.74%
Sharpe1.270.850.50
Sortino1.831.170.67
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VUKE · IE00B810Q5111
RebalixVUKE · IE00B810Q511 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+25.66%+25.78%−0.11%
2024+9.49%+9.63%−0.14%
2023+7.77%+7.90%−0.13%
2021+18.31%+18.40%−0.09%
2020−11.60%−11.58%−0.03%

Distributions · per share, in GBP

Frequency: quarterly · last 12 months: 1.409 GBP (2.99% of NAV) · last ex-date 18 Jun 2026
YearPaymentsTotal (GBP)Dividend yield
202620.8152
202541.349+3.81%
202441.3261+3.95%
202341.2837+3.96%
202241.287+3.99%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 108 securities · top-10 weight = 48.9%
Top holdingsWeight
HSBC Holdings PLC10.4%
Shell PLC7.3%
AstraZeneca PLC7.3%
Rolls-Royce Holdings PLC4.7%
Unilever PLC3.8%
British American Tobacco PLC3.6%
BP PLC3.3%
GSK PLC3.0%
Rio Tinto PLC2.9%
Barclays PLC2.7%
Countries (% of fund)
United Kingdom99.8%Other1.4%Netherlands0.6%Guernsey0.2%
Sectors (% of fund)
Financials28.7%Consumer Staples14.0%Health Care12.1%Industrials11.7%Energy10.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
VUKE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fund-docs.vanguard.com/ie00b810q511_priipskid_en.pdf
Factsheet · fund-docs.vanguard.com/FTSE_100_UCITS_ETF_GBP_Distributing_9509_EU_INT
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00B810Q511
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · VUKE · IE00B810Q5112